Valuation : Ipca Laboratories Limited

Market Cap 49TCr 517.71Cr 446.11Cr 418.28Cr 381.82Cr 719.3Cr 721.59Cr 4.96TCr 1.94TCr 25TCr 1.94TCr 1.9TCr 83TCr P/E 2027 *
32.6x
P/E 2028 * 27.9x
Enterprise Value 48TCr 506.57Cr 436.51Cr 409.27Cr 373.61Cr 703.82Cr 706.06Cr 4.86TCr 1.89TCr 24TCr 1.9TCr 1.86TCr 81TCr EV / Sales 2027 *
4.4x
EV / Sales 2028 * 3.87x
Free-Float
54.94%
Yield 2027 *
0.3%
Yield 2028 * 0.32%
1 day-0.40%
1 week+2.11%
Current month+11.65%
1 month+9.80%
3 months+24.10%
6 months+27.38%
Current year+36.99%
1 week 1,896.85
Extreme 1896.85
1,990.05
1 month 1,645.9
Extreme 1645.9
1,990.05
Current year 1,392
Extreme 1392
1,990.05
1 year 1,252.95
Extreme 1252.95
1,990.05
3 years 857.5
Extreme 857.5
1,990.05
5 years 670
Extreme 670
1,990.05
10 years 200
Extreme 200
1,990.05
Manager TitleAgeSince
Chief Executive Officer 53 01/04/2023
Chief Executive Officer 70 01/04/2023
Chief Tech/Sci/R&D Officer 52 16/10/2023
Director TitleAgeSince
Chairman 79 05/07/2012
Director/Board Member 53 11/11/2008
Director/Board Member 70 01/08/1994
Change 5-day change 1-year change 3-year change Capi.($)
-0.40%+2.11% - - 520.6Cr
-0.13%-6.44%+60.47%+112.05% 1,04800Cr
+0.85%-0.81%+52.77%+63.15% 64TCr
-1.03%-3.58%+22.87%+73.29% 46TCr
-1.46%-4.50%+37.43%+38.41% 36TCr
-0.72%-2.89%+21.86%+36.79% 29TCr
-1.19%-2.21%+1.35%+12.29% 26TCr
-1.05%-1.57%+51.40%+68.55% 24TCr
+0.08%-1.78%-17.64%-54.29% 20TCr
-2.14%-0.30%+29.42%+89.10% 18TCr
Average -0.73%-2.07%+28.88%+48.82% 40.91TCr
Weighted average by Cap. -0.49%-3.02%+38.56%+65.41%

Financials

2027 *2028 *
Net sales 11TCr 115.05Cr 99Cr 93Cr 85Cr 159.84Cr 160.35Cr 1.1TCr 430.26Cr 5.55TCr 431.94Cr 422.54Cr 18TCr 12TCr 128.34Cr 110.59Cr 103.69Cr 95Cr 178.31Cr 178.88Cr 1.23TCr 479.98Cr 6.19TCr 481.85Cr 471.37Cr 21TCr
Net income 1.51TCr 16Cr 14Cr 13Cr 12Cr 22Cr 22Cr 151.9Cr 59Cr 764.52Cr 59Cr 58Cr 2.54TCr 1.78TCr 19Cr 16Cr 15Cr 14Cr 26Cr 26Cr 178.49Cr 70Cr 898.38Cr 70Cr 68Cr 2.98TCr
Net Debt -1.06TCr -11Cr -9.6Cr -9Cr -8.22Cr -15Cr -16Cr -106.81Cr -42Cr -537.61Cr -42Cr -41Cr -1.78TCr -2TCr -21Cr -18Cr -17Cr -15Cr -29Cr -29Cr -200.15Cr -78Cr -1.01TCr -78Cr -77Cr -3.34TCr
Logo Ipca Laboratories Limited
Ipca Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in manufacturing and marketing over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs) covering various therapeutic segments. It offers APIs, such as Atenolol, Chloroquine Phosphate, Chlorthalidone, Furosemide, Hydroxychloroquine sulfate, Losartan, Metoprolol Succinate, Metoprolol Tartrate, Pyrantel Salts and Propranolol. The Company offers brands, such as Zerodol, Lariago, HCQS, Perinorm, Rapither AB, Tenoric, Lumerax, Etova, Fexova, Malirid, Allsuth, Alwiz, AZR 50mg, Bacilon, Cinkona, Clarbact, Glyree MV, Halotop, Luliz, Ozepam, Pacimol, Pari, Xtor-F, Zabpro, Zilast, Ramcor, Sove, Venpower and Folitrax. The Company’s products are sold in over 100 countries across the globe. The Company has 18 manufacturing units in India manufacturing APIs and formulations. Its subsidiaries include Ipca Pharmaceuticals, Inc. and Ipca Pharma Nigeria Ltd.
Employees
17,210
Date Price Change Volume
28/26/28 ₹1,950.75 -0.40% 13,038
27/26/27 ₹1,958.65 +0.35% 3,804
26/26/26 ₹1,951.90 +1.12% 31,703
25/26/25 ₹1,930.20 +0.46% 33,730
24/26/24 ₹1,921.30 +0.57% 22,791
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
1,950.30INR
Average target price
1,972.28INR
Spread / Average Target
+1.13%

Quarterly revenue - Rate of surprise